<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8562886" created="30/10/2006" creator="Junko Matsuura"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>8562886</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">The effect of <term id="T1" lex="Toremifene" sem="Organic_compound_other">Toremifene</term> on the expression of some <term id="A1" sem="DNA_domain_or_region">genes</term> in <term id="T2" lex="human_mononuclear_cell" sem="Cell_natural">human mononuclear cells</term>.</sentence>
<event KT="Other" id="E1">
<type class="Gene_expression"/>
<theme idref="A1"/>
<clue>The effect of Toremifene on the <clueType>expression</clueType> <linkTheme>of</linkTheme> some genes in human mononuclear cells.</clue>
</event>
<event KT="Investigation" id="E2">
<type class="Regulation"/>
<theme idref="E1"/>
<cause idref="T1"/>
<clue>The <clueType>effect</clueType> <linkCause>of</linkCause> Toremifene <linkTheme>on</linkTheme> the expression of some genes <clueLoc>in human mononuclear cells</clueLoc>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term id="T3" lex="Toremifene" sem="Organic_compound_other">Toremifene</term> exerts multiple and varied effects on the <term id="T4" lex="gene_expression" sem="Other">gene expression</term> of <term id="T5" lex="human_peripheral_mononuclear_cell" sem="Cell_natural">human peripheral mononuclear cells</term>.</sentence>
<event KT="Fact" id="E3">
<type class="Regulation"/>
<theme idref="T4"/>
<cause idref="T3"/>
<clue>Toremifene exerts multiple and varied <clueType>effects</clueType> <linkTheme>on</linkTheme> the gene expression <clueLoc>of human peripheral mononuclear cells.</clueLoc></clue>
</event>
<sentence id="S3">After short-term, <term id="T6" lex="in_vitro_exposure" sem="Other">in vitro exposure</term> to <term id="T7" lex="therapeutical_level" sem="Other">therapeutical levels</term>, distinct changes in <cons id="T8" lex="(AND P-glycoprotein_expression steroid_receptors_expression p53_expression Bcl-2_expression)" sem="(AND Other Other Other Other)"><frag id="F1"><term id="A2" sem="Protein_molecule">P-glycoprotein</term></frag>, <frag id="F2"><term id="A3" sem="Protein_molecule">steroid receptors</term></frag>, <frag id="F3"><term id="A4" sem="Protein_molecule">p53</term></frag> and <frag id="F4"><term id="A5" sem="Protein_molecule">Bcl-2</term></frag> <frag id="F5">expression</frag></cons> take place.</sentence>
<event id="E4">
<type class="Gene_expression"/>
<theme idref="A2"/>
<clue>After short-term, in vitro exposure to therapeutical levels, distinct changes in P-glycoprotein, steroid receptors, p53 and Bcl-2 <clueType>expression</clueType> take place.</clue>
</event>
<event id="E5">
<type class="Gene_expression"/>
<theme idref="A3"/>
<clue>After short-term, in vitro exposure to therapeutical levels, distinct changes in P-glycoprotein, steroid receptors, p53 and Bcl-2 <clueType>expression</clueType> take place.</clue>
</event>
<event id="E6">
<type class="Gene_expression"/>
<theme idref="A4"/>
<clue>After short-term, in vitro exposure to therapeutical levels, distinct changes in P-glycoprotein, steroid receptors, p53 and Bcl-2 <clueType>expression</clueType> take place.</clue>
</event>
<event id="E7">
<type class="Gene_expression"/>
<theme idref="A5"/>
<clue>After short-term, in vitro exposure to therapeutical levels, distinct changes in P-glycoprotein, steroid receptors, p53 and Bcl-2 <clueType>expression</clueType> take place.</clue>
</event>
<event KT="Method" id="E8">
<type class="Artificial_process"/>
<theme idref="T3"/>
<clue>After short-term, in vitro <clueType>exposure</clueType> to therapeutical levels, distinct changes in P-glycoprotein, steroid receptors, p53 and Bcl-2 expression take place.</clue>
<comment>NO COREFTHEME</comment></event>
<event id="E9">
<type class="Regulation"/>
<theme idref="E4"/>
<cause idref="E8"/>
<clue>After short-term, in vitro exposure to therapeutical levels, distinct <clueType>changes</clueType> <linkTheme>in</linkTheme> P-glycoprotein, steroid receptors, p53 and Bcl-2 expression take place.</clue>
</event>
<event id="E10">
<type class="Regulation"/>
<theme idref="E5"/>
<cause idref="E8"/>
<clue>After short-term, in vitro exposure to therapeutical levels, distinct <clueType>changes</clueType> <linkTheme>in</linkTheme> P-glycoprotein, steroid receptors, p53 and Bcl-2 expression take place.</clue>
</event>
<event id="E11">
<type class="Regulation"/>
<theme idref="E6"/>
<cause idref="E8"/>
<clue>After short-term, in vitro exposure to therapeutical levels, distinct <clueType>changes</clueType> <linkTheme>in</linkTheme> P-glycoprotein, steroid receptors, p53 and Bcl-2 expression take place.</clue>
</event>
<event id="E12">
<type class="Regulation"/>
<theme idref="E7"/>
<cause idref="E8"/>
<clue>After short-term, in vitro exposure to therapeutical levels, distinct <clueType>changes</clueType> <linkTheme>in</linkTheme> P-glycoprotein, steroid receptors, p53 and Bcl-2 expression take place.</clue>
</event>
<sentence id="S4">In view of the increasing use of <term id="T9" lex="antiestrogen" sem="Lipid">antiestrogens</term> in <term id="T10" lex="cancer_therapy" sem="Other">cancer therapy</term> and <term id="T11" lex="cancer_prevention" sem="Other">prevention</term>, there is obvious merit in <term id="T12" lex="long-term_in_vivo_study" sem="Other">long-term in vivo studies</term> to be conducted.</sentence>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
